An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)
CompletedOBSERVATIONAL
Enrollment
52
Participants
Timeline
Start Date
June 17, 2024
Primary Completion Date
July 18, 2024
Study Completion Date
July 18, 2024
Conditions
Dry Eye
Interventions
DRUG
Optive MEGA-3 (OM3)
Eye Drops
Trial Locations (1)
38104-2211
Southern College of Optometry /ID# 262668, Memphis